|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$22,000
|
N/A
|
National Institutes of Health
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112 00377
|
$41,189
|
|
Abnet, Christian
|
DCEG (NCI)
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Novel Combinatorial Therapeutic Approach for Prostate Cancer
|
5R03CA219336-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
3R01CA195708-05S1
|
$94,087
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-05
|
$382,616
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Policy- and Provider-Level Determinants of Human Papillomavirus Vaccination Disparities Among Young U.S. Women
|
1K01CA234226-01
|
$158,403
|
|
AGENOR, MADINA
|
TUFTS UNIVERSITY MEDFORD
|
|
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
|
4R44CA203336-02
|
$659,516
|
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
5R01CA134633-06
|
$535,071
|
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
|
1R43CA228721-01
|
$299,607
|
|
AKPORIAYE, EMMANUEL
|
VEANA THERAPEUTICS, LLC
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
|
2R44CA192428-02A1
|
$893,847
|
|
ALLEN, MICHAEL
|
EMBOLX, INC.
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-04
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
|
5R21CA213114-02
|
$217,282
|
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
|
3U19CA203654-02S1
|
$147,830
|
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Developing Human Induced Pluripotent Stem Cell Precision Oncology Models
|
1R50CA233164-01
|
$155,981
|
|
ANASTASAKI, CORINA
|
WASHINGTON UNIVERSITY
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-05
|
$303,118
|
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
Development of an MRI-compatible, High-Frequency Irreversible Electroporation (H-FIRE) System for Non-thermal Ablation of Inoperable Brain Tumors
|
1R43CA233158-01
|
$244,498
|
|
ARENA, CHRISTOPHER
|
VOLTMED, INC.
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$298,466
|
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma
|
1R21CA229919-01
|
$213,694
|
|
ASNAGHI, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
|
The impact of e-cigarette use on adolescent uptake and persistence of conventional smoking: Who is most vulnerable?
|
5R01CA202262-03
|
$621,365
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Obesity and Pancreatic Cancer Progression and Survival
|
1K07CA222159-01A1
|
$149,125
|
|
BABIC, ANA
|
DANA-FARBER CANCER INST
|
|
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
|
1R01CA228272-01
|
$659,504
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
3R01CA185623-05S1
|
$68,187
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
5R01CA185623-05
|
$1,038,141
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Dual View Endoscopy for Colonoscopy
|
2R42CA203212-02
|
$872,389
|
|
BANERJEE, BHASKAR
|
OMNISCIENT, LLC
|
|
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
|
1R37CA218413-01A1
|
$414,368
|
|
BANSAL, AASTHAA
|
UNIVERSITY OF WASHINGTON
|
Total relevant funding to Herpes - Genital for this search: $927,903
|